News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. intelligence says Cuba has 300+ military drones and discussed targeting U.S. bases and ships, increasing geopolitical risk.
  • Lockheed is positioned to benefit from rising defense spending, though analysts warn of near-term margin pressure.
  • India raised gold and silver import duties to 15%, likely reducing jewellery demand and pressuring Titan's near-term sales.
  • Early Phase 2 data for NBTXR3 in stage 3 lung cancer showed high overall and complete response rates, supporting further development.
  • A tactical long on D-Wave (QBTS) was recommended based on improving bookings and a sizable cash cushion.
  • RBC pegs Ford Energy's value at $1–$5 billion, keeping battery and storage economics in focus for investors.

Latest Articles

Vertex EVP Sells $126K in Stock as Company Nears 52-Week High

Vertex EVP Sells $126K in Stock as Company Nears 52-Week High

Ourania Tatsis, Executive Vice President at Vertex Pharmaceuticals, sold shares under a pre-established Rule 10b5-1 trading plan, disposing of 1,887 shares across two days for roughly $915,724. The trades were filed on a Form 4 with the SEC. Vertex shares trade near their 52-week high even as the company reported a slight EPS miss for Q4 2025 and a…

Vertex Executive Sells Nearly $1.6M in Stock Across Two Days

Vertex Executive Sells Nearly $1.6M in Stock Across Two Days

Amit Sachdev, Vertex Pharmaceuticals' Executive Vice President and Chief Patient & External Affairs Officer, executed two share dispositions across February 24-25, 2026, via a company-approved 10b5-1 trading plan. The transactions reduced his directly held stake while leaving him with substantial direct and indirect holdings. The stock sales oc…

Vertex Executive Sells $2.39M in Stock as Company Nears 52-Week High

Vertex Executive Sells $2.39M in Stock as Company Nears 52-Week High

Duncan McKechnie, Vertex Pharmaceuticals' Executive Vice President and Chief Commercial Officer, sold a total of 5,783 shares across February 24-25, 2026, generating roughly $2.81 million in proceeds. The transactions were executed under a 10b5-1 plan and reported via a Form 4 filing. The trade comes while Vertex shares trade near their 52-week hig…

Tokyo core inflation eases to 1.8%, dipping below BOJ 2% target

Tokyo core inflation eases to 1.8%, dipping below BOJ 2% target

Tokyo's annual core consumer price inflation slowed to 1.8% in February from 2.0% in January, falling beneath the Bank of Japan's 2% target for the first time since October 2024. A narrower measure that excludes fresh food and fuel rose 2.5%. The slowdown aligns with BOJ projections that fuel subsidies and last year's base effects will temporarily …

Why Capstone Green Energy Looks Like a Conviction Turnaround Long

Why Capstone Green Energy Looks Like a Conviction Turnaround Long

Capstone Green Energy appears to be exiting a multi-year trough and rebuilding a business on higher-margin aftermarket services and incremental product wins. With execution improving, the setup favors a long trade that balances event-driven upside against execution and financing risk. The plan below gives specific entry, target, and stop levels wit…

Exelixis Executive Sells $2.13M in Stock as Firm Posts Mixed Q4 Results

Exelixis Executive Sells $2.13M in Stock as Firm Posts Mixed Q4 Results

Aftab Dana, Executive Vice President for Research and Development at Exelixis, Inc. (NASDAQ: EXEL), sold 47,918 shares on February 24, 2026, for $44.50 per share, totaling $2,132,351. The transaction occurs while third-party analysis flags the stock as trading below its intrinsic value. Exelixis reported a fourth-quarter 2025 EPS beat but missed re…

MOZAYYX Acquisition Corp. closes $300 million IPO on NYSE

MOZAYYX Acquisition Corp. closes $300 million IPO on NYSE

MOZAYYX Acquisition Corp. completed an initial public offering of 30 million units at $10 each, generating $300 million in gross proceeds before underwriting discounts and expenses. The offering included a partial exercise of the underwriter's over-allotment, and the units began trading on the New York Stock Exchange on February 25, 2026. Each unit…

Chicago Holds Public Memorials as Lines Form to Honor Jesse Jackson

Chicago Holds Public Memorials as Lines Form to Honor Jesse Jackson

Public memorial events in Chicago have drawn community members, elected officials and longtime allies to honor Jesse Jackson, whose civil rights work and political organizing left a lasting imprint on American life. A public viewing at Rainbow PUSH Coalition headquarters attracted mourners who queued for nearly two blocks to see Jackson lying in re…

IES Holdings Director Disposes $2.5M in Stock Amid Mixed Quarterly Results

IES Holdings Director Disposes $2.5M in Stock Amid Mixed Quarterly Results

Todd M. Cleveland, a director at IES Holdings, Inc. (NASDAQ: IESC), sold 4,896 shares of common stock between February 24 and February 26, 2026, for roughly $2.5 million. The trades came while the stock trades at $515.05, up 177% over the prior year; recent company results showed a revenue beat but an earnings miss for the first quarter of fiscal 2…